← back to search

Annick You-Ten

University Health Network ·
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Cancer-related Molecular Pathways, Immune Cell Function and Interaction, DNA Repair Mechanisms, and Protein Kinase Regulation and GTPase Signaling.
h-index
20
citations
3,202
works
25
NIH funding
primary concept
Biology
email

Recent publications

Distinct and opposite effects of leukemogenic <i>Idh</i> and <i>Tet2</i> mutations in hematopoietic stem and progenitor cells
Proceedings of the National Academy of Sciences 2023cited by 22position: middledoi
K48-linked KLF4 ubiquitination by E3 ligase Mule controls T-cell proliferation and cell cycle progression
Nature Communications 2017cited by 53position: middledoi
Involvement of Toso in activation of monocytes, macrophages, and granulocytes
Proceedings of the National Academy of Sciences 2013cited by 79position: middledoi
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
Nature 2012cited by 507position: middledoi
The E3 ubiquitin ligase Mule acts through the ATM–p53 axis to maintain B lymphocyte homeostasis
The Journal of Experimental Medicine 2012cited by 65position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tak W. Mak · Nagasaki University4 papers (2012–2023) · 4 papers (2012–2023)Jillian Haight · University Health Network3 papers (2012–2017)Andrew Wakeham · University Health Network3 papers (2012–2017)Pamela S. Ohashi · University Health Network3 papers (2012–2017)Dirk Brenner · University of Luxembourg3 papers (2012–2017)Ari Melnick · Cornell University2 papers (2012–2023)Juan Carlos Zúñiga‐Pflücker · University of Toronto2 papers (2012–2017) · 2 papers (2012–2017) · 2 papers (2012–2017)Yi Sheng · York University2 papers (2012–2017)Gordon S. Duncan · University Health Network2 papers (2012–2017)Cem Meydan · Cornell University1 papers (2023–2023)Evan Lind · University of Portland1 papers (2012–2012)Thorsten Berger · University Health Network1 papers (2023–2023)Philipp A. Lang · Johannes Gutenberg University Mainz1 papers (2012–2012)Stefanie S. Schalm · Blueprint Medicines (United States)1 papers (2012–2012) · 1 papers (2023–2023)Troy M. Robinson · Memorial Sloan Kettering Cancer Center1 papers (2023–2023) · 1 papers (2017–2017)